The Advancing Healthcare Innovation Summit (AHIS2022) is a major healthcare conference and exhibit showcasing the latest innovations related to healthcare and medical sciences. AHIS2022 is a networking conference for all stakeholders in healthcare innovations.
The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Heath’s legacy of delivering Pharmalink in 2022. At PharmaLink, we work to find solutions that will increase confidence in product quality throughout your products’ life cycle management and global supply chain. We do this by aligning with the strategic priorities of the FDA and industry - and by helping participants create network links to drive compliant innovations. The solutions might not be evident within our companies, or our industry, so we explore beyond our industry - beyond borders and beyond comfort zones.
Walsh University is hosting the annual Science and Technology Business Luncheon on Nov 16, 2022. Keynote speaker, Dr. Jason Kalirai, leads the management and oversight of NASA missions at Johns Hopkins APL, including the Double Asteroid Redirection Test (DART). Please come to celebrate the advancement of Science and Technology in the modern-day workforce.
Join us for an exciting announcement about the organization's next evolution. Ohio’s life sciences industry is on the precipice of a generational opportunity to deliver on the promise of economic advancement and well-being for our state’s residents, and accelerate Ohio’s national leadership in this arena. Join life sciences industry leaders and elected officials for a special event on November 17th. You’ll learn about our next evolution in advancing innovation and advocating for the common interests across Ohio’s life sciences community. This includes a new, cross-sector effort to accelerate workforce development that will be a central fuel for progress, today and for the future. Limited space available – RSVP today to secure your spot! There will be time for networking after the presentation concludes.
Northeast Ohio’s Tax Credits Group (TCG), Duffy+Duffy and KIKO Realtors, Auctioneers & Advisors have announced the dates for their annual Fall income tax reduction seminar series, where attendees will learn powerful tax planning tools and strategies to maximize credits and deductions in order to save significant tax dollars for their clients. In this 50-minute session, Tax Credits Group experts will provide attendees with an update on recent legislative, regulatory, and IRS-issued guidance related to both the Research and Development Tax Credit and the Employee Retention Credit. The free, online seminars will be held over 4 separate dates: November 7 & 29 and December 1 & 7.
The Ohio Chamber is holding its inaugural Healthcare Transformation Summit. The summit will bring together stakeholders across the healthcare industry to discuss current challenges, successes, and innovations for tomorrow that will transform healthcare services in order to create a system that is less costly and produces better outcomes for Ohioans. The Summit includes keynote speakers and 17 different panel discussions including topics on access and affordability, workforce development, price transparency, infant mortality and behavioral health. This is a one-day event, with registration opening at 8:30 a.m., the summit starting at 9:30 a.m. and the event ending at 4:00 p.m. BioOhio will be participating in the panel on Workforce Development in Healthcare.
As the private economic development entity for the state of Ohio, JobsOhio has the pleasure of partnering with many great cities and towns to grow our economy. The purpose of this TIGER Talk is to offer the community information about JobsOhio, the Healthcare Sector, and JobsOhio’s programs to support Ohio businesses at varied stages of development.
Healthcare diagnostics has seen a significant increase in over-the-counter (OTC) or direct-to-consumer (DTC) testing. A trajectory that was already in the making prior to COVID-19, this area has increased at a faster pace as more consumers are comfortable performing OTC tests at home. This change in consumer expectation, as well as an evolution of global regulatory requirements, has led to increased considerations and requirements by IVD manufacturers to produce robust testing options. Join NAMSA for this webinar as we evaluate those enhanced requirements specifically as they affect human factors and usability engineering to ensure all IVDs are safe and effective for the intended users, uses and use environments. Early understanding of these requirements is crucial and can influence the device display, controls, functions, results interpretations, instructions and countless other design inputs impacting the consumer.
Ohio Life Sciences has relaunched with a focus on advancing innovation and advocating for the common interests across Ohio’s life sciences community. This includes a new, cross-sector effort to accelerate workforce development that will be a central fuel for progress, today and for the future. OLS is excited to convene our regional life sciences communities across the state and continue to share our mission and build member investor engagement. During this networking event, we will facilitate open dialogue and brainstorming on workforce development opportunities across the state, as well as ways you can get involved to unify industry and education to grow Ohio's life sciences workforce. This FREE event will be hosted by OLS member Dupler Office. Drinks and appetizers will be provided.
Join NAMSA for this webinar where we will discuss the most common approaches used for determining the exhaustive endpoint, their advantages and disadvantages and their influence on study design and results. We will also outline how regulatory requirements and laboratory execution diverge, as well as other challenges of an E&L study that are influenced by a lack of standardized procedures (e.g. mass balance, toxicological assessment).
